PACT Pharma, Inc.   Report issue

For profit Phase 1
Founded: Hayward CA United States (2016)

Organization Overview

First Clinical Trial
2019
NCT03970382
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

PACT Pharma, Inc.

Active Ingredients

Drugs in Phase 1 Trials (2)

neotcr-p1 (1 trial)

nivolumab (opdivo) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2